Matthew Hewitt
Stock Analyst at Craig-Hallum
(2.45)
# 2,435
Out of 5,245 analysts
6
Total ratings
60%
Success rate
17.24%
Average return
Main Sectors:
Stocks Rated by Matthew Hewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CERT Certara | Maintains: Hold | $10 → $8 | $5.24 | +52.67% | 2 | May 12, 2026 | |
| CYRX Cryoport | Initiates: Buy | $15 | $14.00 | +7.14% | 1 | Mar 30, 2026 | |
| APYX Apyx Medical | Maintains: Buy | $5 → $6 | $4.13 | +45.28% | 1 | Mar 11, 2026 | |
| LFCR Lifecore Biomedical | Maintains: Buy | $8 → $10 | $4.94 | +102.63% | 2 | Nov 22, 2024 |
Certara
May 12, 2026
Maintains: Hold
Price Target: $10 → $8
Current: $5.24
Upside: +52.67%
Cryoport
Mar 30, 2026
Initiates: Buy
Price Target: $15
Current: $14.00
Upside: +7.14%
Apyx Medical
Mar 11, 2026
Maintains: Buy
Price Target: $5 → $6
Current: $4.13
Upside: +45.28%
Lifecore Biomedical
Nov 22, 2024
Maintains: Buy
Price Target: $8 → $10
Current: $4.94
Upside: +102.63%